In cell therapy, traditional bioreactors often face challenges such as high shear stress and cell damage caused by mechanical agitation, making it difficult to meet the stringent requirements for cell viability, phenotype, and functionality. To address these challenges, Bioengineering has developed the Ondalis Wave Single-Use Bioreactor, providing an innovative solution for a wide range of cell culture applications.
Ondalis Wave Single-Use Bioreactor
The perfect wave for your cells.Ondalis creates the ideal growth environment: gentle wave motion for sensitive cells with full process control, combined with the reliability of modern single-use culture systems.
• Quick commissioning
• Low shear forces
• Suitable for a wide range of cell culture processes
• Precise monitoring and control of all culture parameters
• Integrated Bio-Bag Integrity Test
• GMP-compliant authority management system
1.Efficient cultivation with modular Wave technology
Ondalis is a Wave single-use bioreactor system for cell culture processes in research and production. The agitation ensures uniform mixing of the medium and efficient gas transfer while gently cultivating sensitive cell lines. This makes the system particularly suitable for cell cultures with high cell densities and demanding cell types. Ondalis supports batch, fed-batch, and perfusion cultures and provides a reliable platform for modern single-use bioprocesses under GMP compliant conditions.
2. Pre-sterilized Single-use Culture Bags
These multi-layered, highly stable, gamma-sterilized, and tested-to-all-standard-specifications single-use culture bags are suitable for cell therapy, vaccine production, and other demanding biotechnological applications. They are easy and safe to handle and support batch, fed-batch, and perfusion cultures to ensure reliable cell proliferation up to high cell densities.
3. BioScada II – Intuitive SCADA for controlling bioprocesses
BioScada II visualizes and analyzes your bioprocess in real time. Freely configurable widgets display critical process parameters, trends and system states exactly where they are needed. Integrated analysis tools enable fast comparison of batches and support data-driven process optimization.
• Freely configurable widgets for process visualization
• Integrated analyzer with batch-tobatch trend comparison
• Setpoint Selector for intuitive cascade control configuration
• Flexible setpoint profiles (e.g. exponential feed strategies)
• Integrated sequencer for custom process workflows
• Remote Service Provider for secure system monitoring and support
Cell therapy offers powerful approaches for treating a wide range of challenging diseases. With its personalized and precise treatment strategies, it has become a key direction in modern medicine. Ondalis supports diverse cell culture processes, delivering flexible and efficient solutions for biopharmaceutical research, development, and commercial manufacturing, while contributing to the continued advancement of the biopharmaceutical industry.
About Bioengineering AG
Bioengineering AG is a global leader in bioreactor technology. With over 50 years of dedicated expertise, the company has built a strong international reputation for professional excellence. Today, Bioengineering AG serves clients worldwide, offering comprehensive solutions that cover the full spectrum of bioreaction and cultivation needs—from laboratory research and pilot-scale development to commercial-scale production. In 2025, Bioengineering AG officially joined the Morimatsu. By synergizing its deep technological foundation with collaborative innovation, the company is committed to driving high-quality, sustainable development across the pharmaceutical, biopharmaceutical, and synthetic biology industries.
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
